Abstract
The correlation between anti–severe acute respiratory syndrome coronavirus 2 antibody levels and infection was reported. Here, we estimated the role of pre–fourth dose levels using data from 1098 healthcare workers. The risk of infection was reduced by 46% (95% confidence interval, 29%–59%) for each 10-fold increase in prebooster levels. Prebooster antibody levels could be used to optimally time boosters.
Original language | English |
---|---|
Pages (from-to) | 1315-1317 |
Number of pages | 3 |
Journal | Clinical Infectious Diseases |
Volume | 76 |
Issue number | 7 |
DOIs | |
State | Published - 3 Apr 2023 |
Keywords
- IgG levels
- SARS-CoV-2
- boosters
- infection risk
- mRNA vaccines
All Science Journal Classification (ASJC) codes
- Microbiology (medical)
- Infectious Diseases